Showing 25 to 36 of 168 results
Diabetes Epidemic Devastates McAllen Family, Exposing City's Health Crisis
In McAllen, Texas, known as "America's fattest city," the Ceron family's tragic history with diabetes—three siblings died from the disease, others experienced amputations and blindness—exposes the city's alarmingly high diabetes rate (19.2% in Hidalgo County vs. 11.6% nationally), highlighting the u...
Diabetes Epidemic Devastates McAllen Family, Exposing City's Health Crisis
In McAllen, Texas, known as "America's fattest city," the Ceron family's tragic history with diabetes—three siblings died from the disease, others experienced amputations and blindness—exposes the city's alarmingly high diabetes rate (19.2% in Hidalgo County vs. 11.6% nationally), highlighting the u...
Progress
48% Bias Score
England's Obesity Crisis Deepens Despite Billions Spent
New data reveals a concerning rise in obesity rates in England, with 67.4% of adults now overweight or obese, despite billions spent on treatment and prevention; West Lindsey has the highest rate at 38.8%, and the crisis costs the NHS over £11 billion annually.
England's Obesity Crisis Deepens Despite Billions Spent
New data reveals a concerning rise in obesity rates in England, with 67.4% of adults now overweight or obese, despite billions spent on treatment and prevention; West Lindsey has the highest rate at 38.8%, and the crisis costs the NHS over £11 billion annually.
Progress
52% Bias Score
Wegovy Shows Promise in Treating Serious Liver Disease
A Novo Nordisk-funded trial shows Wegovy effectively treated MASH in 63% of 800 patients across 37 countries, significantly improving liver inflammation and fibrosis, leading to potential FDA approval by year-end.
Wegovy Shows Promise in Treating Serious Liver Disease
A Novo Nordisk-funded trial shows Wegovy effectively treated MASH in 63% of 800 patients across 37 countries, significantly improving liver inflammation and fibrosis, leading to potential FDA approval by year-end.
Progress
44% Bias Score
Wegovy Ingredient Shows Promise in Treating Fatty Liver Disease
Research published in the New England Journal of Medicine shows that semaglutide, the active ingredient in Wegovy, significantly reduced liver inflammation and scarring in patients with metabolic dysfunction-associated steatohepatitis (MASH), a fatty liver disease affecting an estimated 1.5% to 6.5%...
Wegovy Ingredient Shows Promise in Treating Fatty Liver Disease
Research published in the New England Journal of Medicine shows that semaglutide, the active ingredient in Wegovy, significantly reduced liver inflammation and scarring in patients with metabolic dysfunction-associated steatohepatitis (MASH), a fatty liver disease affecting an estimated 1.5% to 6.5%...
Progress
48% Bias Score
UK to Extend Sugar Tax to Milkshakes
The UK government will extend its sugar tax to milkshakes and other milk-based drinks, lowering the sugar threshold to 4g per 100ml, impacting 203 products (93% of sales) to curb obesity, despite prior exemptions due to calcium concerns, and generating additional revenue.
UK to Extend Sugar Tax to Milkshakes
The UK government will extend its sugar tax to milkshakes and other milk-based drinks, lowering the sugar threshold to 4g per 100ml, impacting 203 products (93% of sales) to curb obesity, despite prior exemptions due to calcium concerns, and generating additional revenue.
Progress
40% Bias Score
Moderate Drinking and Obesity Double Liver Disease Risk
New research shows that even moderate alcohol consumption combined with being overweight doubles the risk of liver disease, highlighting a significant public health concern given the four-fold rise in deaths from this condition over the past two decades and the increasing number of diagnoses in thos...
Moderate Drinking and Obesity Double Liver Disease Risk
New research shows that even moderate alcohol consumption combined with being overweight doubles the risk of liver disease, highlighting a significant public health concern given the four-fold rise in deaths from this condition over the past two decades and the increasing number of diagnoses in thos...
Progress
52% Bias Score
Weight Loss Injections Could Boost UK Economy by £4.5 Billion
Research presented at the European Congress on Obesity in Málaga estimates that providing semaglutide to eligible UK residents could boost the economy by £4.5 billion due to increased productivity among 2,660 trial participants who gained an average of 17 extra workdays annually, offsetting some of ...
Weight Loss Injections Could Boost UK Economy by £4.5 Billion
Research presented at the European Congress on Obesity in Málaga estimates that providing semaglutide to eligible UK residents could boost the economy by £4.5 billion due to increased productivity among 2,660 trial participants who gained an average of 17 extra workdays annually, offsetting some of ...
Progress
44% Bias Score
Weight Loss Injections: Pharmacy Access Planned
A potential multimillion-pound deal could allow pharmacies in England to offer weight loss injections like Ozempic and Wegovy for £9.90 after a short consultation, addressing current NHS limitations and long wait times.
Weight Loss Injections: Pharmacy Access Planned
A potential multimillion-pound deal could allow pharmacies in England to offer weight loss injections like Ozempic and Wegovy for £9.90 after a short consultation, addressing current NHS limitations and long wait times.
Progress
44% Bias Score
WHO to Officially Endorse Weight-Loss Drugs for Obesity Treatment
The World Health Organization will officially endorse weight-loss drugs like Wegovy and Mounjaro for adult obesity treatment in August, addressing the over 1 billion people affected globally, with 70% in low- and middle-income countries, while acknowledging high costs and advocating for increased ac...
WHO to Officially Endorse Weight-Loss Drugs for Obesity Treatment
The World Health Organization will officially endorse weight-loss drugs like Wegovy and Mounjaro for adult obesity treatment in August, addressing the over 1 billion people affected globally, with 70% in low- and middle-income countries, while acknowledging high costs and advocating for increased ac...
Progress
32% Bias Score
Semaglutide Shows Promise in Treating Metabolic-Associated Fatty Liver Disease
A new study published in the New England Journal of Medicine reveals that semaglutide, a key ingredient in popular weight-loss drugs, significantly improved liver inflammation and scarring in patients with metabolic-associated fatty liver disease (MASH) after 72 weeks, with 33% of patients on semagl...
Semaglutide Shows Promise in Treating Metabolic-Associated Fatty Liver Disease
A new study published in the New England Journal of Medicine reveals that semaglutide, a key ingredient in popular weight-loss drugs, significantly improved liver inflammation and scarring in patients with metabolic-associated fatty liver disease (MASH) after 72 weeks, with 33% of patients on semagl...
Progress
40% Bias Score
UK to Extend Sugar Tax to Milkshakes
The UK government plans to extend its sugar tax to milkshakes and similar drinks by July 21, aiming to reduce sugar consumption, despite concerns about the impact on consumers and the success of the initial tax.
UK to Extend Sugar Tax to Milkshakes
The UK government plans to extend its sugar tax to milkshakes and similar drinks by July 21, aiming to reduce sugar consumption, despite concerns about the impact on consumers and the success of the initial tax.
Progress
44% Bias Score
Eli Lilly's Weight-Loss Pill Poised for Market Disruption
Eli Lilly's new weight-loss pill, showing 8% weight loss in trials, offers a more accessible treatment option compared to injectables, potentially reaching a larger patient base and generating \$100 billion in sales by 2030.
Eli Lilly's Weight-Loss Pill Poised for Market Disruption
Eli Lilly's new weight-loss pill, showing 8% weight loss in trials, offers a more accessible treatment option compared to injectables, potentially reaching a larger patient base and generating \$100 billion in sales by 2030.
Progress
64% Bias Score
Showing 25 to 36 of 168 results